Rapid Aortic Measurements

by iSchemaView  · Based in United States → — AI beyond the algorithm™: Intelligent automation for aortic disease and patient surveillance.
Cardiology Radiology Vascular Surgery

Contact for pricing
Regulatory Status Disclosed

Overview

Rapid Aortic Measurements, developed by iSchemaView (doing business as RapidAI), is an AI-powered software product designed to automatically process radiological images, specifically CT scans, to assist clinicians in measuring aortic structures quickly and accurately. This comprehensive deep clinical AI solution aims to transform the acute assessment and longitudinal management of aortic disease.

The software analyzes all CT scans that include the aorta, including post-treatment and non-contrast studies, to aid in the identification of aortic aneurysms, dissections, and other anomalies. It automatically generates critical measurements, including 24 guideline-based metrics (six zonal maximums and eighteen landmark measurements), and produces automated 3D reconstructions of the entire aorta. Rapid Aortic also facilitates longitudinal monitoring by tracking anatomical changes over time through side-by-side comparisons of current and prior scans. Integrated into the Rapid Enterprise™ Platform, it aims to reduce the cognitive burden for radiologists and enable faster reading times, while empowering surgeons and clinicians to more effectively monitor patients.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated processing of CT scans for aortic analysis
  • Rapid and accurate measurement of aortic structures
  • 24 automated guideline-based aortic measurements (6 zonal maximums, 18 landmark metrics)
  • Automated 3D image reconstructions of the entire aorta
  • 2D and 3D visualizations of segmented vessels
  • Longitudinal tracking and comparison of anatomical changes over time
  • Analysis of all CT scans including post-treatment and non-contrast studies
  • Integrated into the Rapid Enterpriseu2122 Platform
  • Personalized notifications via PACS, email, or Rapid Mobile app
  • Aids in reducing cognitive burden for radiologists and improving reading times

Use Cases

  • Acute assessment of aortic disease (aneurysms, dissections, other anomalies)
  • Longitudinal management and surveillance of aortic disease
  • Pre-procedure planning for aortic interventions
  • Earlier detection of aortic aneurysms and dissections
  • Monitoring post-treatment aortic changes
  • Workflow triage and prioritization for radiologists and clinicians

What Physicians Need to Know

Cardiac CT/MRI Analysis
Rapid Aortic is an FDA-cleared AI-enabled software primarily for computed tomography (CT) evaluation of the aorta. It provides 24 automated aorta measurements, automated 3D image reconstructions, and facilitates earlier detection of aortic aneurysms and dissections on CT exams. The tool also supports longitudinal monitoring of pertinent anatomical changes over time.
AHA/ACC Guideline Alignment
The software offers 24 guideline-based measurements and advanced visualization, which can significantly improve pre-procedure planning and monitoring. Its automated, guideline-driven capabilities aim to reduce variability and support adherence to Society of Vascular Surgery and American College of Cardiology guidelines for aortic disease management.
Cardiac Monitoring Integration
Rapid Aortic facilitates longitudinal monitoring of aortic pathology and anatomical changes. It integrates into the Rapid Enterpriseu2122 Platform, Rapid Navigator Pro, Rapid mobile and web applications, PACS, EHR, and reporting systems, creating a seamless and secure experience for clinicians.
Real-Time Alert Capability
The tool is designed to alert providers to longitudinal changes in aortic measurements and allows for personalized notifications to coordinate care, supporting timely interventions.
Physician Tip

Leverage Rapid Aortic's automated measurements and 3D reconstructions for efficient identification, confident assessment, and diligent longitudinal monitoring of aortic patients. The tool's ability to analyze all CT scans that include the aorta, including post-treatment and non-contrast studies, can reduce cognitive burden and reading times for radiologists, while empowering surgeons and clinicians for more effective patient management and earlier detection of critical changes. Utilize the automatic side-by-side comparison to prior scans for quick assessment of aortic changes.

Rapid Aortic is built on the Rapid Enterpriseu2122 Platform and is fully integrated into the Rapid Edge Cloud. Its modules are seamlessly integrated into Rapid Navigator Pro, Rapid mobile, and web applications, ensuring a cohesive workflow across PACS, EHR, and reporting systems for accessing, comparing, and acting on critical findings without disrupting existing clinical workflows.

Details

Category Cardiology AI
Pricing Contact for pricing
DeploymentCloud, On-premise, Hybrid
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

Rapid Aortic Measurements (K251987) received FDA 510(k) clearance on September 23, 2025. It is an AI-powered software product designed to automatically process radiological images to assist clinicians in measuring aortic structures quickly and accurately for the acute assessment and longitudinal management of aortic disease.

Integrations
EHR Not specified
Specialties Cardiology, Radiology, Vascular Surgery

What the Web Says

Rapid Aortic Measurements, part of Rapid Aortic by RapidAI, is an AI-driven solution designed to automate the assessment and longitudinal management of aortic diseases. It has received FDA clearance and aims to assist clinicians in quickly and accurately identifying aortic aneurysms, dissections, and other anomalies. The software provides automated measurements, 3D reconstructions, and tracks anatomical changes over time, potentially reducing cognitive burden for radiologists and improving patient monitoring.

Overall: Positive

Strengths

  • Automated, precise analysis and 3D reconstruction of aortic structures from CT scans.
  • Provides 24 automated guideline-based measurements, including zonal maximums and landmark metrics.
  • Facilitates earlier detection of aortic aneurysms and dissections.
  • Reduces cognitive burden for radiologists and accelerates reading times.
  • Enables robust longitudinal tracking for surveillance with automatic side-by-side comparison to prior scans.
  • Integrated into Rapid Edge Cloud and Rapid Navigator Pro, offering seamless and secure experience across PACS, EHR, and reporting systems.

Limitations

  • Manual measurement can be time-consuming, labor-intensive, and prone to inter-observer discrepancy.
  • Some studies on AI models for aortic measurement omit aortic root measurement.
  • The diagnostic performance of AI tools may not accurately reflect situations where the AI correctly classified patients but the reference standard did not.
  • Concerns exist regarding the medico-legal implications and liability in cases of false negatives with AI triage.
  • Different imaging techniques and even different radiologists can lead to variations in measurements.

Based on reviews from: RapidAI, Diagnostic Imaging, DAIC, Slashdot, Annals of Translational Medicine, ResearchGate, Reddit (r/aortic_aneurysm, r/Radiology, r/radiologyAI, r/AskDocs, r/ausjdocs), Everyday Health, accessdata.fda.gov, Medical Product Outsourcing, NCBI Bookshelf, PMC, X-ray Interpreter

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rapid Aortic Measurements

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

X-ray Interpreter (RadAI Slice)
Rapid Aortic Measurements | FDA Radiology AI Device
Rapid Aortic Measurements, an AI-powered software by iSchemaView, Inc., received FDA approval on September 23, 2025, to automatically process radiological images for quick and accurate measurement of aortic structures. This device is intended to assist clinicians in decision-making and is indicated for adults.
2025-09
accessdata.fda.gov
510(k) Premarket Notification - K251987
This FDA document details the 510(k) premarket notification for Rapid Aortic Measurements (K251987) by iSchemaView, Inc., outlining its substantial equivalence to predicate devices and compliance with safety and effectiveness requirements. The software is designed for image analysis and measurement of aortic and iliac arteries in CT imaging datasets.
2025-09
BEUDAMED
Rapid Aortic Measurements - BEUDAMED
Rapid Aortic Measurements (K251987) is classified as an FDA Class 2 medical device with a traditional clearance type and falls under the radiology medical specialty. It was cleared on September 23, 2025.
2025-09
FDA
TPLC - Total Product Life Cycle - FDA
This FDA page lists Rapid Aortic Measurements (K251987) among other devices from iSchemaView, Inc., indicating its inclusion in the Total Product Life Cycle database. It highlights the device's role in medical image management and processing using AI.
2026-07
RapidAI.com
RapidAI Clinical Solutions
RapidAI offers 'Rapid Aortic Measurements' as part of its cardiac & vascular solutions, providing AI-driven tools to help risk-stratify patients, expand access to care, and track disease progression. The platform aims to deliver decision-grade intelligence across critical conditions.
unknown
X-ray Interpreter (RadAI Slice)
Rapid DeltaFuse | FDA Radiology AI Device
This article mentions Rapid Aortic Measurements as another device from iSchemaView Inc., alongside Rapid DeltaFuse, both receiving 510K clearance in 2025. It indicates a broader portfolio of AI-powered radiology devices from the company.
2025-08
X-ray Interpreter (RadAI Slice)
Rapid ASPECTS (v3) | FDA Radiology AI Device
Rapid Aortic Measurements is listed among other devices from iSchemaView, Inc., such as Rapid ASPECTS (v3), highlighting the company's range of FDA-cleared AI radiology devices.
2024-01
Physician AI Tools
Rapid Aortic Measurements vs RX-1 Rhythm Express Remote Cardiac Monitoring System
This comparison article from Physician AI Tools lists 'Rapid Aortic Measurements' as a tool for evaluating aortic and iliac arteries from CT scans, contrasting it with other cardiac monitoring systems. It provides an overview of its functionality within the broader landscape of AI-powered medical devices.
unknown

Videos

Product demos, reviews, and walkthroughs for Rapid Aortic Measurements.

View all on YouTube

Frequently Asked Questions

AI-powered solutions automate the measurement of aortic diameters from CT and MRI scans, significantly reducing the time and labor associated with manual methods. This automation enhances diagnostic efficiency, provides consistent, guideline-based measurements, and facilitates earlier detection and longitudinal monitoring of aortic pathologies like aneurysms and dissections.
While promising, AI models may exhibit varying performance on real-world data and require prospective validation to assess their impact on patient outcomes and clinician workflow. Some tools are currently limited to experimental or retrospective settings, and their efficacy can depend on the completeness and quality of the input imaging data.
Physicians should look for AI solutions that have undergone rigorous clinical validation and received regulatory clearances, such as FDA 510(k) clearance, which indicates the software can enhance detection and provide guideline-based measurements. These validated tools aim to reduce inter-reader variability and standardize measurement methodologies, improving consistency in diagnosis and treatment decisions.
The primary alternative to AI is manual measurement by radiologists and other specialists, which is considered the gold standard for diagnosis, surgical planning, and monitoring. However, manual measurement is time-consuming, labor-intensive, and susceptible to human error and inter-observer variability, which AI aims to mitigate by providing consistent and rapid results.
While specific pricing varies by vendor and solution, AI in cardiology is a growing market, with solutions often integrated into existing hospital systems like PACS. The return on investment can come from improved efficiency, faster reading times, earlier detection of critical conditions, and potentially better patient outcomes, which can reduce costly late-stage interventions.
AI models are trained on vast datasets, and their performance can be influenced by the diversity of this training data. While designed to provide objective measurements, physicians must be aware that models may exhibit varying performance on real-world data and should be used as adjunctive tools, complementing clinical expertise rather than replacing it.
Many AI solutions are designed for seamless integration into existing hospital IT infrastructure, including EHR, PACS, scheduling, and reporting systems. They often operate on cloud-based platforms with on-premise capabilities, providing automated analysis of CT scans and delivering results directly into the clinical workflow for efficient review and care coordination.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from iSchemaView

Rapid NCCT Stroke
iSchemaView
Neurology AI
Rapid NCCT Stroke by iSchemaView (RapidAI) is an FDA-cleared AI-powered software that analyzes non-contrast CT images for suspected Intracranial Hemorrhage (ICH) and Large Vessel Occlusion (LVO), enabling faster stroke triage and treatment decisions.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.